Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Q3 2025 value amounting to $2686.0.

  • Tonix Pharmaceuticals Holding's Non-cash Items fell 9591.12% to $2686.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2686.0, marking a year-over-year decrease of 9591.12%. This contributed to the annual value of $936.0 for FY2024, which is 9964.0% down from last year.
  • Latest data reveals that Tonix Pharmaceuticals Holding reported Non-cash Items of $2686.0 as of Q3 2025, which was down 9591.12% from $2294.0 recorded in Q2 2025.
  • Over the past 5 years, Tonix Pharmaceuticals Holding's Non-cash Items peaked at $892008.0 during Q1 2023, and registered a low of $936.0 during Q4 2024.
  • Its 3-year average for Non-cash Items is $209743.9, with a median of $65691.0 in 2024.
  • As far as peak fluctuations go, Tonix Pharmaceuticals Holding's Non-cash Items tumbled by 3572.92% in 2024, and later plummeted by 9968.88% in 2025.
  • Quarter analysis of 3 years shows Tonix Pharmaceuticals Holding's Non-cash Items stood at $259991.0 in 2023, then plummeted by 99.64% to $936.0 in 2024, then surged by 186.97% to $2686.0 in 2025.
  • Its Non-cash Items stands at $2686.0 for Q3 2025, versus $2294.0 for Q2 2025 and $1784.0 for Q1 2025.